ERBB2 and neoplasm: Of the 12 tumor specimens identified, review of IHC and follow-up fluorescence in situ hybridization (FISH) at or near the time of resection revealed that 6 specimens were known to be clinically HER2-positive and 6 specimens were HER2-negative.